112 filings
Page 5 of 6
8-K
0ew8n7q d61lqeqzehsb
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
otlmz2
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
fil90y3xegket6xn6z
14 May 21
Quarterly report
4:31pm
8-K
lk7p8vjr jk7a2smq99
6 Apr 21
Entry into a Material Definitive Agreement
4:30pm
10-K
j7xpj wk5lc
31 Mar 21
Annual report
4:30pm
8-K
5dwzdsowd
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
EFFECT
utr0tkrvjsuiql8fxz
5 Feb 21
Notice of effectiveness
12:15am
UPLOAD
973hi0gc1k
3 Feb 21
Letter from SEC
12:00am
CORRESP
ajl3c
3 Feb 21
Correspondence with SEC
12:00am
S-3
o9tf qdjj8dt
29 Jan 21
Shelf registration
4:48pm
8-K
mbhl1spwu1 0mr2
25 Jan 21
Departure of Directors or Certain Officers
5:11pm
S-8
taclp44a1z8z
22 Jan 21
Registration of securities for employees
4:15pm
8-K
auszw
19 Jan 21
Regulation FD Disclosure
9:10am
8-K/A
cbvp1q8hltkd
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
7kf0ij ww8
15 Dec 20
Departure of Directors or Certain Officers
5:14pm
8-K
ssvgf
10 Dec 20
Completion of Acquisition or Disposition of Assets
5:28pm
8-K
m7uwwwc2evn5oy0
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-A12B
rprlkkc5
1 Dec 20
Registration of securities on exchange
9:25am
SEC STAFF
3mfc af3dsw6h
3 Nov 20
SEC staff action: Order
12:00am